RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,281,139 | -20.1% | 1,076,587 | 0.0% | 0.03% | -52.9% |
| Q4 2022 | $1,604,115 | -8.6% | 1,076,587 | 0.0% | 0.07% | -20.5% |
| Q3 2022 | $1,755,000 | +105.0% | 1,076,587 | 0.0% | 0.09% | +95.6% |
| Q2 2022 | $856,000 | -55.8% | 1,076,587 | 0.0% | 0.04% | -35.7% |
| Q1 2022 | $1,938,000 | +5.3% | 1,076,587 | 0.0% | 0.07% | -19.5% |
| Q4 2021 | $1,841,000 | -17.0% | 1,076,587 | 0.0% | 0.09% | +40.3% |
| Q3 2021 | $2,218,000 | -10.8% | 1,076,587 | 0.0% | 0.06% | -60.5% |
| Q2 2021 | $2,487,000 | -17.2% | 1,076,587 | 0.0% | 0.16% | -10.3% |
| Q1 2021 | $3,004,000 | -2.1% | 1,076,587 | 0.0% | 0.18% | -22.2% |
| Q4 2020 | $3,068,000 | +35.7% | 1,076,587 | 0.0% | 0.22% | +6.6% |
| Q3 2020 | $2,261,000 | -53.8% | 1,076,587 | 0.0% | 0.21% | -62.6% |
| Q2 2020 | $4,898,000 | – | 1,076,587 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |